Testing immune-boosting therapy before surgery or radiation for advanced lung cancer

This trial is testing whether immunotherapy—a treatment that helps your immune system fight cancer—can shrink tumors enough to make surgery or radiation therapy possible for people with advanced lung cancer. Normally, some patients' tumors are too large or their health makes these curative treatments too risky. The study gives immunotherapy first, then reassesses whether curative treatment becomes an option.

Many patients with advanced lung cancer cannot receive surgery or radiation therapy because their tumors are too large or their health makes these treatments unsafe. This trial explores whether the medication can shrink tumors enough to open the door to curative treatment options that might otherwise be impossible.